After years studying the medical industry, one pattern stands out more clearly than any other to me: ethical principles bend predictably toward whatever generates revenue. The industry's public image, altruistic healers guided by Hippocratic ideals, often clashes with its behaviour. Seemingly irreconcilable positions suddenly make sense once you view them through the lens of economic self-interest.
Consider two prominent examples that reveal the underlying logic. On one hand, medical authorities and much of the establishment fiercely defend a mother's "absolute right" to abort her unborn child, framing it as bodily autonomy and reproductive healthcare. On the other, the same voices insist that mothers cannot refuse childhood vaccinations, even on conscientious or religious grounds, because doing so supposedly endangers the child and the community. The contradiction is glaring: absolute bodily autonomy in one case, mandatory intervention "for the child's own good" in the other.
If ethics were truly consistent, bodily autonomy would apply across the board or the duty to protect life would be paramount in both. Instead, outcomes align remarkably well with financial incentives. Abortion is a profitable, scalable procedure with repeat customers in some demographics, supported by a powerful political and legal infrastructure. Vaccination, meanwhile, represents one of the most reliable, recurring revenue streams in pharmaceutical history: government-backed, mandated, and defended against liability. The ethical framework conveniently expands or contracts to protect the cash flow.
This money-first dynamic appears repeatedly across modern medicine. Look at the recent discussion around bone health and osteoporosis. For decades, the industry pushed bisphosphonate drugs and aggressive screening while downplaying simpler, less profitable interventions like adequate vitamin D, magnesium, weight-bearing exercise, and proper nutrition. The Midwestern Doctor's analysis highlights how modern medical practices, from over-reliance on certain pharmaceuticals to dietary and lifestyle factors shaped by processed food interests, have contributed to widespread bone weakness. Treatments that manage symptoms long-term (repeat prescriptions, scans, specialist visits) are prioritised over approaches that might resolve underlying issues more cheaply and permanently. The "ethical" standard becomes whatever sustains the economic model.
The same pattern explains other inconsistencies. Statins are pushed aggressively for broad populations despite marginal benefits for many and well-documented side effects, because they are blockbuster drugs. Opioid prescribing spiralled under the banner of "pain as the fifth vital sign" until the human and legal costs became too great, all while non-pharmaceutical pain management options received less enthusiasm. Hormone replacement therapy, antidepressants, ADHD medications: each has faced waves of enthusiastic adoption followed by quiet re-evaluation, with financial interests heavily shaping the timeline and tone of both enthusiasm and retreat.
Critics are often dismissed as "anti-science" or conspiracy theorists for pointing this out. But one need not posit cartoonish villains in boardrooms to recognise structural incentives. Medical research, regulatory bodies, continuing education, and clinical guidelines are heavily influenced by pharmaceutical funding. Journals depend on advertising and reprint revenue. Specialists build practices around reimbursed procedures. Hospitals and health systems optimise for billable services. In such an environment, ethical language becomes a flexible tool: "patient autonomy" when it expands markets or shields profitable choices; "public health duty" and "evidence-based medicine" when it enforces compliance with high-margin interventions.
This is not to say every doctor or researcher is consciously corrupt. Most operate within the incentives presented to them. The system rewards certain behaviours and marginalises others. Studies that support profitable interventions find funding and prominence more easily. Sceptical voices face higher hurdles for publication, promotion, or institutional acceptance. Over time, the ethical consensus drifts toward the economically viable position.
Acknowledging this reality does not require rejecting all of modern medicine. Many advances are genuine and valuable. But it does demand intellectual honesty. When ethical principles prove remarkably elastic: celebrating choice in one domain while demanding obedience in another, we should ask cui bono? Who benefits financially? The answer frequently illuminates the contradiction.
True medical ethics would start from first principles: do no harm, prioritise the patient's long-term wellbeing, respect informed consent, and pursue truth over institutional convenience. Reconciling today's inconsistencies requires confronting how deeply economic forces shape what we call "ethics." Until we do, patients will continue to navigate a system where the moral compass too often points toward the bottom line: MONEY!
https://www.midwesterndoctor.com/p/how-modern-medicine-made-your-bones